MedTrace Logo

Virtual Parental Presence on Induction of Anesthesia vs Premedication With Midazolam

NCT05834049 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2026-04-24

No results posted yet for this study

Summary

This multi-center, prospective, clinical trial targets recruiting children undergoing inhalational induction of anesthesia. The primary objective of this study is to assess the Modified Yale Preoperative Anxiety Scale during induction between children receiving oral midazolam 0.5 mg/kg (max 20 mg) versus virtual parental presence on induction of anesthesia. Patients will be randomized to one of two groups by block randomization.

Conditions

Interventions

BEHAVIORAL

Virtual Parental Presence on Induction of Anesthesia

Apple Inc's FaceTime™ video application will be used when the child is taken to the operating room

BEHAVIORAL

Midazolam

Preoperative midazolam (0.5 mg/kg of oral midazolam with a maximum dose of 20mg) will be given unless medically contraindicated.

Sponsors & Collaborators

Principal Investigators

  • Vanessa Olbrecht, MD, MBA · Nationwide Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2026-12-31
Completion
2027-12-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05834049 on ClinicalTrials.gov